推薦產品
化驗
99%
形狀
solid
mp
39-41 °C (lit.)
官能基
bromo
SMILES 字串
BrCc1cccc(Br)c1
InChI
1S/C7H6Br2/c8-5-6-2-1-3-7(9)4-6/h1-4H,5H2
InChI 密鑰
ZPCJPJQUVRIILS-UHFFFAOYSA-N
尋找類似的產品? 前往 產品比較指南
一般說明
3-Bromobenzyl bromide undergoes reduction with diethylzinc in the presence of Pd(PPh3)4 to yield corresponding hydrocarbon.
應用
3-Bromobenzyl bromide was used in the synthesis of:
- 1,7-di(3-bromobenzyl)cyclen
- substituted 8-arylquinoline, phosphodiesterase 4 (PDE4) inhibitors
訊號詞
Danger
危險聲明
危險分類
Skin Corr. 1B
儲存類別代碼
8A - Combustible corrosive hazardous materials
水污染物質分類(WGK)
WGK 3
閃點(°F)
235.4 °F - closed cup
閃點(°C)
113 °C - closed cup
個人防護裝備
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
客戶也查看了
Synthesis of a new family of bi-and polycyclic compounds via Pd-catalyzed amination of 1, 7-di (3-bromobenzyl) cyclen.
Tetrahedron Letters, 49(24), 3950-3954 (2008)
Reduction of benzylic halides with diethylzinc using tetrakis (triphenylphosphine) palladium as catalyst.
The Journal of Organic Chemistry, 58(24), 6908-6910 (1993)
Bioorganic & medicinal chemistry letters, 15(23), 5241-5246 (2005-09-20)
The discovery and SAR of a new series of substituted 8-arylquinoline PDE4 inhibitors are herein described. This work has led to the identification of several compounds with excellent in vitro and in vivo profiles, including a good therapeutic window of
Journal of combinatorial chemistry, 11(1), 14-33 (2008-12-25)
Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computational stages of D(3) is the global rehearsal of prospective reagents and
Journal of combinatorial chemistry, 11(1), 34-43 (2008-12-25)
For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducibly make new, high quality, molecules with potential for biological activity. This article reports
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務